respiratory syncytial virus Archives - Express Pharma

AstraZeneca to launch Palivizumab (Synagis) in India

US FDA expands approval to GSK’s Arexvy for adults aged 50-59, at increased risk

Moderna’s mRESVIA FDA approval paves way for mRNA vaccines across multiple indications: GlobalData

AstraZeneca and Sanofi Beyfortus to dominate RSV market in China: GlobalData

Biden administration to urge Americans get COVID-19 boosters

Pfizer and GSK to battle for share of new RSV vaccine market: GlobalData

New RSV therapies may accelerate the emergence of drug-resistant strains: GlobalData

Sanofi and AstraZeneca win EU approval for prevention of infant RSV

Nirsevimab gets Promising Innovative Medicine Designation from MHRA